What a buyer sees
MCAREAVEY PHARMA LTD
Dispensing chemist in specialised stores · Belfast · NI674652
Nobody can see what you turn over
2.3× spreadYou file abbreviated accounts, as almost every company your size does, so the profit and loss account is not on public record. That band is what your balance sheet implies to anyone who looks: 4 figures against 61 companies in the same trade. An opening offer is built on the bottom of it.
What your filings show moving
How you sit in your trade
slowest tenth typical fastest tenth youEach spread is companies in the same trade and size that did publish a turnover. Creditor days are shown but not marked: neither end of that one is plainly good.
What a buyer would ask 4
- Your turnover is not on fileYou file abbreviated accounts, as most companies your size do, so a buyer cannot see what the business turns over and has to estimate it. Working only from what you filed, the range lands between £375k and £848k. An opening offer is built on the low end of whatever they guess.
- The newest accounts on file are 32 months oldAnyone looking at the company today is reading a year that has already ended. Whatever has improved since is invisible.
- One director on the registerA buyer's first question about a company run by one person is what happens to it if that person stops. It is usually the first thing priced.
- No website on file against the companyThe first thing anyone does with a company number is look for the business behind it. Finding nothing is its own answer.
What a buyer would like 0
Nothing stands out yet from the filings alone.
What the register says
Owners
- 45since 2020
Directors
- 45since 2020
| Year to | Turnover | Staff | Cash |
|---|---|---|---|
| 2023-12-31 | not filed | 5 | £65k |
| 2022-12-31 | not filed | 5 | £63k |
| 2021-12-31 | not filed | 4 | £102k |
A rough bracket, and why it is only that
0.25–0.5× salesThe turnover range is fitted on UK companies that did file one. The multiple is a published sector average from Dutch mid-market deals, not from your own numbers and not from your own market. Treat this as the opening bracket of a conversation, not a valuation.